Literature DB >> 16972078

The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction.

Jonathan M Flanagan1, Alexandra L Gerber, Jean Lud Cadet, Ernest Beutler, Jack C Sipe.   

Abstract

The human fatty acid amide hydrolase (FAAH) missense mutation c.385 C-->A, which results in conversion of a conserved proline residue to threonine (P129T), has been associated with street drug use and problem drug abuse. Although a link between the FAAH P129T variant and human drug abuse has been reported, the extent of risk and specific types of substance addiction vulnerability remain to be determined. Here, we investigated the relationship of the FAAH P129T variant to a number of linked single nucleotide polymorphisms to establish a haplotyping system, calculate the estimated age and origin of the FAAH 385 C-->A mutation and evaluate its association with clinically significant drug addiction in a case control study. The results showed a significant over-representation of the FAAH P129T homozygotes in 249 subjects with documented multiple different drug addictions compared to drug free individuals of the same ethnic backgrounds (P = 0.05) using logistic regression analysis controlling for ethnicity. To increase the logistic regression analysis power by increasing the sample size, the data from our previous study (Sipe et al. in Proc Natl Acad Sci USA 99:8394-8399, 2002) were pooled with the present cohort which increased the significance to P = 0.00003. Investigation of the FAAH chromosomal backgrounds of the P129T variant in both multiple different drug addicted and control subjects revealed a common ancestral haplotype, marked population differences in haplotype genetic diversity and an estimated P129T mutation age of 114,425-177,525 years. Collectively, these results show that the P129T mutation is the only common mutation in the FAAH gene and is significantly associated with addictive traits. Moreover, this mutation appears to have arisen early in human evolution and this study validates the previous link between the FAAH P129T variant and vulnerability to addiction of multiple different drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16972078     DOI: 10.1007/s00439-006-0250-x

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  19 in total

1.  Nomenclature for the description of human sequence variations.

Authors:  J T den Dunnen; S E Antonarakis
Journal:  Hum Genet       Date:  2001-07       Impact factor: 4.132

2.  Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity.

Authors:  Aron H Lichtman; Donmienne Leung; Christopher C Shelton; Alan Saghatelian; Christophe Hardouin; Dale L Boger; Benjamin F Cravatt
Journal:  J Pharmacol Exp Ther       Date:  2004-06-30       Impact factor: 4.030

Review 3.  The fatty acid amide hydrolase (FAAH).

Authors:  N Ueda; R A Puffenbarger; S Yamamoto; D G Deutsch
Journal:  Chem Phys Lipids       Date:  2000-11       Impact factor: 3.329

4.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.

Authors:  B F Cravatt; K Demarest; M P Patricelli; M H Bracey; D K Giang; B R Martin; A H Lichtman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

5.  Evolution of the hemoglobin S and C genes in world populations.

Authors:  Y W Kan; A M Dozy
Journal:  Science       Date:  1980-07-18       Impact factor: 47.728

6.  Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.

Authors:  Angelo Jayamanne; Ruth Greenwood; Vanessa A Mitchell; Sevda Aslan; Daniele Piomelli; Christopher W Vaughan
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

7.  Microsatellite variation and recombination rate in the human genome.

Authors:  B A Payseur; M W Nachman
Journal:  Genetics       Date:  2000-11       Impact factor: 4.562

8.  Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use.

Authors:  Kyle P Chiang; Alexandra L Gerber; Jack C Sipe; Benjamin F Cravatt
Journal:  Hum Mol Genet       Date:  2004-07-14       Impact factor: 6.150

9.  A missense mutation in human fatty acid amide hydrolase associated with problem drug use.

Authors:  Jack C Sipe; Kyle Chiang; Alexandra L Gerber; Ernest Beutler; Benjamin F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

Review 10.  Patterns of human genetic diversity: implications for human evolutionary history and disease.

Authors:  Sarah A Tishkoff; Brian C Verrelli
Journal:  Annu Rev Genomics Hum Genet       Date:  2003       Impact factor: 8.929

View more
  37 in total

1.  Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity.

Authors:  O Gunduz-Cinar; K P MacPherson; R Cinar; J Gamble-George; K Sugden; B Williams; G Godlewski; T S Ramikie; A X Gorka; S O Alapafuja; S P Nikas; A Makriyannis; R Poulton; S Patel; A R Hariri; A Caspi; T E Moffitt; G Kunos; A Holmes
Journal:  Mol Psychiatry       Date:  2012-06-12       Impact factor: 15.992

2.  Genetic variation in FAAH is associated with cannabis use disorders in a young adult sample of Mexican Americans.

Authors:  Whitney E Melroy-Greif; Kirk C Wilhelmsen; Cindy L Ehlers
Journal:  Drug Alcohol Depend       Date:  2016-06-25       Impact factor: 4.492

3.  Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment.

Authors:  L Cinnamon Bidwell; Jarrod M Ellingson; Hollis C Karoly; Sophie L YorkWilliams; Leah N Hitchcock; Brian L Tracy; Jost Klawitter; Cristina Sempio; Angela D Bryan; Kent E Hutchison
Journal:  JAMA Psychiatry       Date:  2020-08-01       Impact factor: 21.596

4.  Severity of alcohol dependence is associated with the fatty acid amide hydrolase Pro129Thr missense variant.

Authors:  Matthew E Sloan; Joshua L Gowin; Jia Yan; Melanie L Schwandt; Primavera A Spagnolo; Hui Sun; Colin A Hodgkinson; David Goldman; Vijay A Ramchandani
Journal:  Addict Biol       Date:  2017-02-01       Impact factor: 4.280

Review 5.  Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome.

Authors:  Didier Jutras-Aswad; Jennifer A DiNieri; Tibor Harkany; Yasmin L Hurd
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-02       Impact factor: 5.270

6.  Risky alcohol consumption in young people is associated with the fatty acid amide hydrolase gene polymorphism C385A and affective rating of drug pictures.

Authors:  Kora-Mareen Bühler; Evelio Huertas; Víctor Echeverry-Alzate; Elena Giné; Eduardo Moltó; Lluis Montoliu; Jose Antonio López-Moreno
Journal:  Mol Genet Genomics       Date:  2014-01-10       Impact factor: 3.291

Review 7.  Amygdala FAAH and anandamide: mediating protection and recovery from stress.

Authors:  Ozge Gunduz-Cinar; Matthew N Hill; Bruce S McEwen; Andrew Holmes
Journal:  Trends Pharmacol Sci       Date:  2013-10-25       Impact factor: 14.819

8.  Genetic risk signatures of opioid-induced respiratory depression following pediatric tonsillectomy.

Authors:  Jacek Biesiada; Vidya Chidambaran; Michael Wagner; Xue Zhang; Lisa J Martin; Jaroslaw Meller; Senthilkumar Sadhasivam
Journal:  Pharmacogenomics       Date:  2014-11       Impact factor: 2.533

9.  Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1.

Authors:  D Proudnikov; T Kroslak; J C Sipe; M Randesi; D Li; S Hamon; A Ho; J Ott; M J Kreek
Journal:  Pharmacogenomics J       Date:  2009-12-15       Impact factor: 3.550

Review 10.  Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.

Authors:  V Kiran Vemuri; David R Janero; Alexandros Makriyannis
Journal:  Physiol Behav       Date:  2007-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.